WO2011003596A2

WO2011003596A2 - Perfumed cosmetic preparation containing glycyrrhetinic acid

Info

Publication number: WO2011003596A2
Application number: PCT/EP2010/004126
Authority: WO
Inventors: Lucia Zanforlin Trede; Claudia Steikert; Alexandra Blohm
Original assignee: Beiersdorf Ag
Priority date: 2009-07-06
Filing date: 2010-07-06
Publication date: 2011-01-13
Also published as: DE102009032244A1; EP2451433A2; WO2011003596A3

Abstract

The present invention relates to a cosmetic preparation containing glycyrrhetinic acid and perfume substances.

Description

Description Glvcyrrhetinsäure containing, perfumed cosmetic preparation

The present invention relates to a cosmetic preparation containing glycyrrhetinic acid and perfumes.

The desire to look beautiful and attractive is inherently rooted in man. Although the ideal of beauty has undergone changes over time, the pursuit of an impeccable appearance has always been the goal of man. An essential part of a beautiful and attractive appearance is the condition and appearance of the skin.

For the skin to fulfill its biological functions to the full extent, it needs regular cleaning and care. Cleansing of the skin serves to remove dirt, sweat and remnants of dead skin particles, which form an ideal breeding ground for pathogens and parasites of all kinds. Skin care products are mostly used for

Moisturizing and moisturizing the skin. Frequently they are added active ingredients that regenerate the skin or protect against the harmful effects of UV radiation.

Cosmetics usually contain a number of perfumes, which are intended to mask unpleasant odors of cooking ingredients and the

Cosmetic to give the individual, manufacturer-typical smell. A disadvantage of the prior art, however, is that the scent perfume formed from perfumes is only limited storage stability. In particular, under the influence of heat and light, premature escape of the more volatile perfume components or thermal decomposition or reaction of individual constituents may occur on a regular basis. Even under the influence of light, it can lead to the decomposition or reaction of the individual perfume ingredients, as most

Perfumes via reactive groups, for example aldehyde or keto functions,

Have double bonds and / or ester groups. The consequence of a lack of storage stability is a weakening and / or fragrance change over time.

It was therefore the object of the present invention to eliminate or at least significantly reduce the disadvantages of the prior art and to increase the stability of the perfume scent of cosmetic preparations. Surprisingly, the objects are achieved by a cosmetic preparation comprising a) glycyrrhetinic acid and

b) one or more perfumes,

and by the use of glycyrrhetinic acid to increase the stability of the

Perfume fragrances of cosmetic preparations.

Due to the complexity of the odor phenomena, the quality of perfumed

Cosmetics are usually examined and evaluated by an olfactory trained specialist with the help of odor tests. This test method was also based on the present invention.

Although the person skilled in the art knows DE 10 2006 009783, DE 10 2006 009 850 and DE 10 2007 041 473, these documents could not point the way to the present invention, since these publications deal with the skin-tanning effect of glycerrhetinic acid and give no indications whatsoever to provide the stability increase. WO 2004/009038, which deals with the antibacterial properties of glycerylic acid in cosmetic preparations, could not point the way to the present invention.

The terms "according to the invention", "advantageous according to the invention" etc. refer in the context of the present disclosure both to the preparation according to the invention and to the use according to the invention, even if this is not particularly noted. Embodiments of the preparation according to the invention also include the use according to the invention. The embodiments which are advantageous according to the invention can serve to further increase the effect according to the invention.

It is inventively advantageous if the preparation according to the invention glycyrrhetinic acid in a concentration of 0.01 to 1 wt .-%, based on the total weight of

Preparation containing.

The glycyrrhetinic acid according to the invention is also known to the experts under the chemical name 3β-hydroxy-11-oxoolean-12-ene-30-acid (generic name: enoxolone, bioson).

It is inventively advantageous if the preparation perfumes in one

Total concentration of 0.05 to 2.5 wt .-%, based on the total weight of

Preparation contains. Embodiments of the present invention which are advantageous according to the invention are characterized in that the perfume substances used are one or more compounds selected from the group consisting of the compounds linalool, benzyl benzoates, hydroxyisohexyl 3-cyclohexenes

Carboxaldehyde, Hexyl Cinnamal, Benzyl Salicylate, Citronellol, Coumarin, Limonene,

Butylphenyl methylpropional, geraniol, alpha-isomethyl-ionone can be used.

Embodiments of the present invention which are preferred according to the invention are characterized in that the perfume substances used are one or more compounds selected from the group consisting of the compounds linalool, benzyl benzoates, hydroxyisohexyl 3-cyclohexenes

Carboxaldehyde, hexyl cinnamal, benzyl salicylates, citronellol, coumarin can be used.

Particularly preferred embodiments according to the invention are characterized in that the preparation contains no nitromusschus compounds such as musk ambrette, musk mosquito, musk xylene, musk ketone.

The preparation according to the invention can be present as an aqueous or aqueous-alcoholic preparation or gel, as a hydrodispersion or as an emulsion. The preferred embodiment according to the invention is the emulsion.

If the preparation according to the invention is in the form of an emulsion, then it is

According to the invention preferred, when the emulsion is an O / W emulsion (oil-in-water emulsion).

If the preparation according to the invention is in the form of an O / W emulsion, it is

according to the invention, characterized in that the preparation comprises one or more O / W emulsifiers selected from the group of the compounds glyceryl stearate citrate, glyceryl stearate (self-emulsifying), stearic acid, stearate salts, polyglyceryl-3-methylglycose distearate, ceteareth-20, PEG-40 stearate, sodium cetearyl sulfate, sucrose

Polystearate containing sodium stearoyl glutamate. Furthermore, it is advantageous in terms of

Cetearyl alcohol in combination with PEG-40 castor oil,

Sodium cetearyl sulfate and glyceryl stearate. In addition, it is advantageous according to the invention to use potassium cetyl phosphate as emulsifier.

According to the invention, it is particularly preferred if the preparation with the aid of

To emulsify a combination of cetearyl alcohol, PEG-40 castor oil, sodium cetearyl sulfate and glyceryl stearate. According to the invention, these O / W emulsifiers according to the invention may advantageously be present in a concentration of from 0.001 to 10% by weight and preferably in a concentration of from 0.1 to 7% by weight, based on the total weight of the preparation.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation has a pH of from 5 to 8.

The pH can be advantageously adjusted according to the invention with the aid of citric acid / citrate buffer, phosphoric acid / phosphate buffer or lactic acid / lactate buffer.

It is advantageous according to the invention if the preparation according to the invention comprises one or more active substances selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, carnitine, carnosine, natural and / or synthetic isoflavonoids, creatine , Creatinine, taurine, β-alanine, licochalcone A,

Glyceryl glucose, tocopherol, tocopheryl acetate, vitamin D and / or its derivatives.

It is advantageous according to the invention if the preparation according to the invention comprises one or more UV filters selected from the group of the compounds phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid salts; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methylene-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-Benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-i - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol ; 3- (4-methylbenzylidene) camphor; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene); 3-benzylidene camphor; ethylhexyl salicylate; 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; Terephthalidendicamphersulfonsäure; 4- (dimethylamino) benzoic acid (2-ethylhexyl) ester; A- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 4-methoxycinnamic acid (2-ethylhexyl) ester; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; 4- (tert-butyl) -4'-methoxydibenzoylmethane; homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-bis

Ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer;

Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the CAS No. 288254-16-0); 4,4 ', 4 "- (1, 3,5-triazin-2 ₁ 4 ₁ 6-triyltriimino) -tris-benzoic acid tris (2-ethylhexyl) (also: 2,4,6-tris- [anilino- (p-carbo-2'-ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - {[4- (2-ethyl-hexyloxy) -2 -hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: Bis- Ethylhexyloxyphenol methoxyphenyl triazine); 2,4,6-tris- (biphenyl) -1, 3,5-triazine; 2,4-bis (4'-di-pentylaminobenzalmalonate) -6- (4 "-butylaminobenzoate) -s-triazine, 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine-N- (ethyloxysulfate ester salt), Titanium dioxide, zinc oxide, merocyanines, piperazine derivatives.

The inventively advantageous merocyanines are selected from the group of compounds

The piperazine derivative advantageous according to the invention can be the following compound:

It is advantageous according to the invention if the preparation according to the invention is free of p-methylbenzylidene camphor.

It is inventively preferred if the preparation contains as UV filter 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene). In such a case, it is advantageous according to the invention if the preparation 2-ethylhexyl-2-cyano-3,3-diphenyl acrylate (octocrylene) in a concentration of 0.5 to 7.5 wt .-%, based on the total weight of the preparation , contains.

It is preferred according to the invention if the preparation according to the invention contains 4- (tert-butyl) -4'-methoxydibenzoylmethane as a further UV filter. In such a case, it is advantageous according to the invention if the preparation contains 4- (tert-butyl) -4'-methoxydibenzoylmethane in a concentration of 0.5 to 5 wt .-%, based on the total weight of the preparation.

Particular preference is given in accordance with the invention to preparations which contain as UV filter system a mixture of 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene), 4- (tert-butyl) -4'-methoxydibenzoylmethane, 2,4 Bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine), 2- Phenylbenzimidazole-5-sulfonic acid salts and titanium dioxide.

Embodiments of the present invention which are advantageous according to the invention are characterized in that the preparation according to the invention contains one or more compounds selected from the group of alcohols, diols, glycols, glycerol.

It is advantageous according to the invention if the preparation according to the invention contains humectants such as glycerol, lactic acid and / or lactates, in particular sodium lactate, butylene glycol, Propylene Glycol, Biosaccaride Gum-1, Glycine Soy, Ethylhexyloxyglycerol,

Pyrrolidoncarbonsäure, hyaluronic acid, chitosan and / or urea contains.

The cosmetic preparations according to the invention may also advantageously, although not necessarily, contain fillers which are e.g. B. the sensory and cosmetic

Further improve the properties of the formulations and, for example, cause or enhance a velvety or silky feel on the skin. Advantageous fillers in the sense of

Starch and starch derivatives (such as, for example, tapioca starch,

Distarch phosphate, aluminum or sodium starch, octenylsuccinate and the like),

Pigments which have neither primarily a UV filter effect nor a coloring effect (such as. For example, boron nitride etc.) and / or Aerosils ^® (CAS no. 7631-86-9), talc, Lauroyl Lysine and Acrylonitrile- methacrylonitriles-methyl methacrylates.

The aqueous phase of the preparations according to the invention may advantageously comprise customary cosmetic auxiliaries, for example alcohols, in particular those of low C number, preferably ethanol and / or isopropanol, diols or polyols of low C number and their ethers, preferably propylene glycol, 2-methylpropane-1, 3-diol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analogous products, polymers, foam stabilizers, electrolytes, self-tanning agents.

Embodiments of the present invention that are advantageous according to the invention are characterized in that the preparation contains, as thickener, one or more compounds selected from the group of the compounds acrylate / C 10 -C ₃₀ -alkyl acrylate, xanthan gum, tapioca starch.

According to the invention, the preparation according to the invention can advantageously contain one or more preservative substances. Embodiments preferred according to the invention are then characterized in that the preparation contains methylparaben, propylparaben, and / or phenoxyethanol.

The oil phase of the preparation according to the invention is advantageously selected from the group of polar oils, for example from the group of lecithins and fatty acid triglycerides, namely the triglycerol esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 8 to 24, in particular 12 to 18 C atoms. The fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semi-synthetic and natural oils, such. Cocoglyceride, olive oil, special flowering oil, jojoba oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, castor oil, wheat germ oil, grape seed oil, thistle oil, evening primrose oil, macadamia nut oil and the like.

Also advantageous according to the invention are z. As natural waxes of animal and vegetable origin, such as beeswax and other insect waxes and berry wax, shea butter and / or lanolin (wool wax).

In the context of the present invention, further advantageous polar oil components can furthermore be selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of from 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or or unbranched alcohols having a chain length of 3 to 30 carbon atoms and from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms. Such ester oils can then advantageously be selected from the group consisting of phenethyl benzoate, 2-phenylethyl benzoate, isopropyl lauroyl sarcosinate, phenyl trimethicone, cyclomethicone, dibutyl adipate, octyl palmitate, octyl cocoate, octyl isostearate,

Octyldodeceyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2- Octyl dodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, tridecyl stearate, tridecyl trimellitate, as well as synthetic, semi-synthetic and natural mixtures of such esters, such as, for example, B. jojoba oil.

Furthermore, the oil phase can be advantageously selected from the group of dialkyl ethers and dialkyl carbonates, are advantageous z. B. dicaprylyl ether (Cetiol OE) and / or dicaprylyl, for example, that available under the trade name Cetiol CC in the company. Cognis.

It is also advantageous that tylglykoldiheptanoat or oil components from the group consisting of isoeicosane, neopentyl, propylene glycol dicaprylate / dicaprate, caprylic / capric / diglyceryl succinate, butylene glycol dicaprylate / dicaprate, C ₂ .i ₃ alkyl lactate, di-C ₁₂ -i ₃ -Alkyltartrat , Triisostearin, dipentaerythrityl hexacaprylate / hexacaprate, propylene glycol monoisostearate, tricaprylin, dimethylisorboride. It is particularly advantageous if the oil phase of the formulations of the invention has a content of Ci ₂ -i ₅ -alkyl benzoate or consists entirely of this.

Advantageous oil components are also z. Butyloctyl salicylate (for example that available under the trade name Hallbrite BHB from the company CP Hall), tridecyl salicylate (which is available under the trade name Cosmacol ESI from the company Sasol), C12-C15 Alkyl salicylate (available under the tradename Dermol NS from Alzo), hexadecyl benzoate and butyl octyl benzoate, and mixtures thereof (Hallstar AB).

Any mixtures of such oil and wax components are also advantageous to use in the context of the present invention.

Furthermore, the oil phase can also advantageously contain non-polar oils, for example those which are selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, Vaseline (petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutenes, C13- 16 isoparaffin and isohexadecane. Among the polyolefins, polydecenes are the preferred substances.

The preparations according to the invention may furthermore advantageously contain one or more substances from the following group of siloxane elastomers, for example the

To increase water resistance and / or the sun protection factor of the products:

(a) siloxane elastomers containing the units R ₂ SiO and RSiOi, ₅ and / or R ₃ SiO ₀ , ₅ and / or SiO ₂ ,

wherein the individual radicals R are each independently hydrogen, Ci _-24- alkyl (such as methyl, ethyl, propyl) or aryl (such as phenyl or ToIyI), alkenyl (such as vinyl) and the weight ratio of the units R ₂ SiO to RSiOi _{i5 is selected} from the range of 1: 1 to 30: 1;

(b) siloxane elastomers which are insoluble and swellable in silicone oil, which are characterized by

Addition reaction of an organopolysiloxane (1) containing silicon-bonded hydrogen with an organopolysiloxane (2) containing unsaturated aliphatic groups, are available,

the amount used being such that the amount of hydrogen of the organopolysiloxane (1) or of the unsaturated aliphatic groups of the organopolysiloxane (2)

In the range of 1 to 20 mol%, if the organopolysiloxane is not cyclic and

In the range of 1 to 50 mol%, when the organopolysiloxane is cyclic.

Advantageously in the context of the present invention, the siloxane elastomer (s) are in the form of spherical powders or in the form of gels.

Advantageously present in the form of spherical powders siloxane elastomers are those with the INCI name dimethicone / vinyl dimethicone crosspolymer, for example available from DOW CORNING under the trade designations DOW CORNING 9506 Powder.

It is advantageous if the siloxane elastomer is used in combination with oils of hydrocarbons of animal and / or vegetable origin, synthetic oils, synthetic esters, synthetic ethers or mixtures thereof.

According to the invention, particularly preferred embodiments of the present invention are characterized in that the preparation comprises one or more lipophilic components selected from the group of compounds myristyl myristate, octyldodecanol, C ₁₂ -C ₅ -, contains benzoate, Butylenglycoldicaprylat / dicaprate Ceatylalkohol.

Advantageous in the context of the present invention are preparations for the care of the skin. They may be used for cosmetic sunscreen, skin care (for example for the prevention and treatment of skin aging) and decorative cosmetics.

The preparations may be sprayable or may be presented on a carrier (eg cloth).

Comparative test

The inventive effect could be proven by the following comparative experiment:

The following preparations were prepared and the smell of

Preparations evaluated by staff trained for perfume testing. For this purpose, a defined amount of the preparation was applied to neutral cardboard cards and subjected to an odor test. The evaluation was done using the following scheme:

Evaluation of perfume tests:

Conclusion: The preparations according to the invention have a more stable perfume fragrance.

¹ containing linalool, benzyl benzoates, hydroxyisohexyl 3-cyclohexenes, carboxaldehyde, hexyl cinnamal, benzyl salicylates, citronellol, coumarin Examples

The following examples are intended to illustrate the present invention without limiting it. The information always refers to weight%, unless otherwise stated.

^* = containing linalool, benzyl benzoates, hydroxyisohexyl 3-cyclohexenes carboxaldehyde,

Hexyl cinnamal, benzyl salicylate, citronellol, coumarin

Claims

claims

1. Cosmetic preparation containing

a) glycyrrhetinic acid and

b) one or more perfumes.

2. Use of glycyrrhetinic acid for increasing the stability of the perfume fragrance of cosmetic preparations.

3. Cosmetic preparation according to claim 1 or use according to claim 2,

characterized in that as perfuming one or more compounds selected from the group of compounds linalool, benzyl benzoates, hydroxyisohexyl 3-cyclohexenes carboxaldehyde, hexyl cinnamal, benzyl salicylates, citronellol, coumarin be used.

4. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation contains glycyrrhetinic acid in a concentration of 0.01 to 1 wt .-%, based on the total weight of the preparation.

5. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation contains perfumes in a total concentration of 0.05 to 2.5 wt .-%, based on the total weight of the preparation.

6. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation is in the form of an emulsion.

7. Cosmetic preparation according to one of the preceding claims, characterized

characterized in that the preparation is in the form of an O / W emulsion.

8. Cosmetic preparation according to one of the preceding claims, characterized

in that the preparation is prepared by means of an emulsifier system

Cetearyl alcohol, PEG-40 castor oil, sodium cetearyl sulfate and glyceryl stearate is emulsified.

9. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation has a pH of 5 to 8.

10. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation one or more

Active substances selected from the group of the compounds alpha-lipoic acid, folic acid, phytoene, D-biotin, coenzyme Q10, alpha-glucosylrutin, camitin, carnosine, natural and / or synthetic isoflavonoids, creatine, creatinine, taurine, β-alanine, licochalcone A, Glyceryl glucose, tocopherol, tocopheryl acetate, vitamin D and / or its derivatives.

11. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation one or more UV filters selected from the group of compounds phenylene-1, 4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonsäuresalze; 2-phenylbenzimidazole-5-sulfonic acid salts; 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and its salts; 4- (2-oxo-3-bomylidenemethyl) benzene sulfonic acid salts; 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid salts; 2,2'-methyl-bis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) -phenol); 2- (2H-benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- [1,3,3,3-tetramethyl-1 - [(trimethylsilyl) oxy] disiloxanyl] propyl] -phenol; 3- (4-methylbenzylidene) camphor; 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrylene); 3-benzylidenecamphor; ethylhexyl salicylate; Hexyl 2- (4'-diethylamino-2'-hydroxybenzoyl) benzoate; Terephthalidendicamphersulfonsäure; 2-ethylhexyl 4- (dimethylamino) benzoate; 4- (dimethylamino) benzoic acid amyl ester; 4-Methoxybenzalmalon-säuredi (2-ethylhexyl) ester; 2-ethylhexyl 4-methoxycinnamate; Isoamyl 4-methoxycinnamate; 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone; 2,2'-dihydroxy-4-methoxybenzophenone; 4- (tert-butyl) -4'-methoxydibenzoylmethane; homomenthyl; 2-ethylhexyl 2-hydroxybenzoate; dimethicodiethylbenzalmalonate; 3- (4- (2,2-ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer;

Dioctylbutylamidotriazone (INCI: diethylhexyl-butamidotriazone); 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) -imino] -6- (2-ethylhexyl) -imino-1,3,5-triazine with the CAS No. 288254-16-0); ^4.4> 4 "- (1, 3,5-triazine-2,4,6-triyltriimino) -tris-benzoic acid tris (2-ethylhexyl) (also: 2,4,6-tris- [anilino- (p-carbo-2 ^l -ethyl-1'-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone); 2,4-bis - {[4- (2-ethylhexyloxy) -2 -hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: bis-ethylhexyloxyphenol methoxyphenyl triazine); 2,4,6-tris- (biphenyl) -1, 3,5- triazine; 2,4-bis- (4'-di-neopentylaminobenzalmalonate) -6- (4 "- butylaminobenzoate) -s-triazine, 4-dicyanomethylene-2,6-dimethyl-1,4-dihydropyridine N- (ethyloxysulfate ester salt), titanium dioxide, zinc oxide, merocyanines, piperazine derivatives.

12. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation contains as thickening agent one or more compounds selected from the group of compounds acrylate / C ₁₀ -C ₃₀ - alkyl acrylate, xanthan gum, tapioca starch.

13. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation methylparaben,

Propylparaben, and / or phenoxyethanol contains.

14. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation contains one or more lipophilic constituents selected from the group of the compounds myristyl myristate,

Octyldodecanol, Ci ₂ -Ci ₅ alkyl benzoate, Butylenglycoldicaprylat / dicaprate, ceatyl alcohol contains.

15. Cosmetic preparation or use according to one of the preceding

Claims, characterized in that the preparation does not contain nitro musk compounds.